@dansfera: Did you see the valuation gap on this biotech play? 🤯 While competitors like CRISPR and Intellia trade at significant cash multiples, this stock is hovering near 1x cash—a statistical outlier! Industry heavyweights like HC Wainwright and Clear Street are screaming undervalued, setting price targets near $10 if positive catalysts arrive. The market disconnect could self-correct its way upward. 👀 #Biotech #StockMarket #Investing #UndervaluedStocks #StockPicks